Sergey Yashin

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Until recently, anticoagulant therapy after catheter ablation of atrial fibrillation, were connected with vitamin K antagonists and drugs of heparin series. New era of novel anticoagulants - dabigatran, rivaroxaban and apixaban is coming up. Our own experience of use in clinical practice of rivoroxaban for patient undergoing catheter ablation of atrial(More)
Dynamics of blood pressure (BP) and heart rate (HR) was traced by automatic monitoring every 30 min uninterruptedly along several months in a patient suffering from combined atrial fibrillation and heart failure during the development of disease and its therapeutic and surgical treatment (pacemaker implanting and atrioventricular ablation). Analyses of(More)
Until recently, anticoagulant therapy after catheter ablation of atrial fibrillation, were connected with vitamin K antagonists and drugs of heparin series. New era of novel anticoagulants--dabigatran, rivaroxaban and apixaban is coming up. Our own experience of use in clinical practice of rivoroxaban for patient undergoing catheter ablation of atrial(More)
  • 1